The Drug Discoverer

Professor Paul Workman is Chief Executive and President of The Institute of Cancer Research, London. He is also Harrap Professor of Pharmacology and Therapeutics and has been instrumental in progressing more than 20 cancer drugs into clinical trials. He spent nearly two decades as Director of the Cancer Research UK Cancer Therapeutics Unit at the ICR, which he built up to become the world's largest academic cancer drug discovery group. Professor Workman writes and talks extensively about challenges facing the cancer drug ecosystem.